Cellyan Biotechnology Co. Ltd (HKPD)
HKPD trades on Nasdaq in Health Care, Other Pharmaceuticals. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.1049
-1.59% on the day
Market cap
$5.1M
Nano cap
Revenue · 2024
$20.3M
No prior year to compare
Net income · 2024
-$27K
-0.1% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-03-31, https://www.sec.gov/Archives/edgar/data/2007702/000121390025076725/0001213900-25-076725-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-03-31.
Profile
| Field | Value |
|---|---|
| Ticker | HKPD on Nasdaq |
| Sector | Health Care |
| Industry | Other Pharmaceuticals |
| Country | Hong Kong |
| IPO year | 2025 |
| SEC CIK | 0002007702 |
| SEC industry code | Wholesale-Drugs, Proprietaries & Druggists' Sundries |
| Incorporated in | E9 |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $20.3M |
| Net income | -$27K |
| Operating income | Not in SEC XBRL data |
| Net margin | -0.1% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document REGISTRATION STATEMENT | F-3 | 2026-06-12 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-08-07 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-09-24 |
Source: SEC EDGAR submissions feed, 66 recent filings. All filings on EDGAR.
Peers in Other Pharmaceuticals
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MEDS | DataMeds AI Inc. | $3.03 | -1.30% | $13.7M |
| COSM | Cosmos Health Inc. | $0.3829 | +9.53% | $38.5M |
| ESYN | EnerSyn Global Inc. | $2.03 | +3.57% | $60.3M |
| ZSTK | ZeroStack Corp. | $4.37 | 0.00% | $95.4M |
| NUS | Nu Skin Enterprises Inc. | $5.01 | +2.88% | $243.9M |
| HLF | Herbalife Ltd. Common Shares | $14.21 | +4.41% | $1.5B |
| CAH | Cardinal Health Inc. | $239.72 | +0.69% | $55.5B |
| COR | Cencora Inc. | $330.11 | +1.55% | $63.0B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier